Documente Academic
Documente Profesional
Documente Cultură
College of Nursing
Prepared By: Joshua James L. Diao, MN, CRN, RM, RN
Neuroscience of Psychiatry and Psychiatric Nursing Pathophysiology of Mental
Illnesses
Introduction
The Diagnostic and Statistical Manual of Mental Disorders, Text Revision, Fourth Edition (DSMIV-TR).
Published in 2000 by the American Psychiatric Association.
Official Classification System used by all mental health professionals to diagnose psychiatric
disorders.
Contains diagnostic criteria for 17 major categories of mental disorders.
A similar system is used in Europe called the International Statistical Classification of
Diseases and Related Health Problems (ICD)
Both ICD and DSM-IV-TR use the same numerical codes for each disorder.
II.
1. Schizophrenia
- Characterized by changes in:
Affect (ambivalent, constricted, inappropriate responsiveness; loss of empathy
with others)
Behavior (withdrawn, aggressive, bizarre)
Thinking (distortion of reality, sometimes with hallucinations and delusions)
Cognition
Five Types:
A. Disorganized (Hebephrenic) Type
- Disorganized thinking, giggling, shallow and inappropriate affect, silly and
regressive behavior and mannerisms, frequent somatic complaints, and
occasional transient and unorganized delusions and hallucinations.
B. Undifferentiated Type
- Disorganized behavior with prominent delusions and hallucinations
C. Catatonic Type
A. Excited Subtype characterized by excessive and sometimes violent motor activity.
B. Withdrawn Subtype characterized by generalized inhibition, stupor, mutism,
negativism, waxy flexibility, and in some cases a vegetative state.
D. Paranoid Type
- Characterized by persecutory or grandiose delusions and sometimes by
hallucinations or excessive religiosity, and the patient is often hostile and
aggressive.
E. Residual signs of schizophrenia, after a psychotic schizophrenic episode, in
patients who are no longer psychotic. (occurs during the residual phase as a form of
Postpsychotic Depressive Disorder of Schizophrenia)
2. Delusional (Paranoid) Disorder
- Associated with persistent delusions (eromatic, grandiose, jelous, persecutory
somatic, unspecified)
Paranoia rare condition characterized by gradual development of an elaborate
delusional system with grandiose ideas; it has a chronic course; the rest of the
personality remains intact.
3. Brief Psychotic Disorders less than 4 weeks in duration brought on by an external
stressor.
4. Schizophreniform Disorder similar to schizophrenia, with delusions, hallucinations,
and incoherence, but lasts less than 6 months.
5. Schizoaffective Disorder characterized by a mixture of schizophrenic symptoms and
pronounce elation (bipolar type) or depression (depressive type)
III.
Personality Disorders
- Disorders characterized by deeply ingrained, generally lifelong maladaptive
patterns of behavior that are usually recognizable at adolescence or earlier.
Psychiatric History
III.
IV.
Mental Status
A. Appearance
1. Personal identification
- Brief nontechnical description of the patients appearance and behavior, as a
novelist may write it.
- Attitude towards examiner (cooperative, attentive, interested, frank, seductive,
defensive, hostile, playful, ingratiating, evasive, or guarded)
2. Behavior and Psychomotor Activity:
- gait, mannerisms, tics, gestures, twitches, touching examiner, echopraxia,
clumsy, rigid, retarded, hyperactive, agitated, combative or waxy.
3. General Description
- Posture, bearing, clothes, grooming, hair, nails; healthy, sickly, angry, frightened,
apathetic, perplexed, poised, old looking, young looking, effeminate, masculine
- Signs of Anxiety moist hands, perspiring forehead, restlessness, tense posture,
strained voice; shifts in level of anxiety during interview or with particular topic.
(50% of Eye Contact is Normal)
B. Speech:
- Rapid, slow, pressured, hesitant, emotional, monotonous, loud, whispered,
slurred, mumbled, stuttering, echolalia, intensity, pitch, ease, spontaneity,
manner, reaction time, vocabulary.
Maltaxial Classification
A.
Axis I: All Clinical Syndromes and other conditions that may be focus of clinical attention (e.g
Mood Disorders, Schizophrenia)
Axis II: Includes personality disorders and mental retardation (Including Defense Mechanisms)
NOTE: Axis I and II can coexist. The Axis I or II condition that is responsible for bringing the
patient to the facility is called the principle or main diagnosis.
Axis III: Includes any general medical conditions (e.g Epilepsy, Cardiovascular Disease,
Endocrine Disorder)
NOTE: if a medical disorder is considered the cause of the psychiatric disorder, it is listen in Axis
I
Axis IV: use to describe psychosocial and environmental problems relevant to the illness (e.g
Divorce, Injury, Death of Loved One)
Axis V: Assessment of Global Functioning exhibited by the patient during the interview. (e.g
Social, Occupational, and Psychological Function)
Continuum from 100 (Superior Functioning) to 1 (Grossly Impaired Functioning)
Code
1
Enduring
Circumstances
No enduring
circumstances that
4
5
CLINICAL NOTES:
-
B. Severity of Disorder
1. Mild few if any symptoms are present and no more than minor impairment in social
or occupational functioning.
2. Moderate symptoms or functional impairment between mild and severe are
present.
3. Severe many symptoms or particularly severe symptoms are present that result in
marked impairment in social or occupational functioning.
4. In Partial Remission the full criteria for the disorder were previously met, but
currently only some of the symptoms or signs of the disorder remain.
5. In Full Remission there are no longer symptoms or signs of the disorder.
VI.
Laboratory Test
A. Renal and Hepatic Tests
- Serum Blood Urea Nitrogen (BUN) and creatinine are monitored in patients
taking lithium (Escalith)
- If Elevated see 2-hour creatinine clearance, and ultimately a 24-hour creatinine
clearance.
Other Test for Patients Taking Lithium: (ALL: Prior to Treatment and Yearly)
1. Complete Blood Count
2. Serum Electrolytes
VII.
Test Related to Psychotropic Drugs
1. Antipsychotics
- NO SPECIFIC TEST
- Primarily Metabolized in the Liver
- Primarily Excreted in Urine
- Peak Plasma Concentration: 2-3 Hours (Oral Dose)
- Elimination Half-Life: 12-30 Hours (or much longer)
- Steady State: atleast 1 week at constant dose
NURSES NOTES:
With the exception of clozapine (Clozaril) all antipsychotics acutely cause elevation in serum
prolactin. GYNECOMASTIA!
Clozapine: Risk for Agranulocytosis (1-2%), Assess Baseline WBC Count before initiation of
Treatment. RISK FOR INFECTION!
A normal prolactin level often indicates either noncompliance or nonabsorption
Side-Effects:
-
Leukocytosis
Leukopenia
Impaired Platelet Function
Mild Anemia (Both Aplastic and Hemolytic)
Agranulocytosis
ECG Changes Prolonged QT Interval; Flattened, Inverted, or bifid T Waves;
and U Waves.
Pharmacologic Function:
Decreases Norepinephrine Release - Decreases Mania
Increases Serotonin Synthesis Alleviates Depression
Lithium itself may have antipsychotic activity
EFFECTIVE ANTISUICIDE DRUG
Indication:
Prophylactic treatment of manic episodes (direct antimanic effects may take up to 2 weeks)
Coupled with antipsychotics for treatment of acute manic episodes
5. Provocation of Panic Attacks with Sodium Lactate
- Up to 72% of patients with panic disorder have a panic attack when administered
an intravenous (IV) injection of sodium lactate.
- Therefore: LACTATE PROVOCATION IS USED TO CONFIRM A DIAGNOSIS
OF PANIC DISORDER
NURSES NOTES:
- Can trigger flashbacks in patients with PTSD PROVIDE SAFETY and
REASSURANCE!
simultaneously affects both limbs and involves functions so specialized that they
are localized to only one hemisphere.
Ideational apraxia
- occurs when the individual components of a sequence of skilled acts can be
performed in isolation, but the entire series cannot be organized and executed as
a whole.
-
[Basal Ganglia]
- A subcortical group of gray matter nuclei, appear to mediate postural tone.
The four functionally distinct ganglia are the striatum, the pallidum, the substantia nigra, and
the subthalamic nucleus.
Collectively known as the corpus striatum, the caudate and putamen harbor components of
both motor and association systems.
A. Caudate Nucleus plays an important role in the modulation of motor acts. Anatomical
and functional neuroimaging studies have correlated decreased activation of the caudate
with obsessive and compulsive behavior.
When functioning properly, the caudate nucleus acts as a gatekeeper to allow the motor system
to perform only those acts that are goal directed.
When it fails to perform its gatekeeper function, extraneous acts are performed as in obsessive
compulsive disorder or in the tic disorders, such as Tourette's disorder.
Overactivity of the striatum owing to lack of dopaminergic inhibition (e.g., in parkinsonian
conditions) results in bradykinesia, an inability to initiate movements.
B. Substantia Nigra is named the black substance because the presence of melanin pigment
causes it to appear black to the naked eye.
Produces the neurotransmitter Dopamine
Aphasia Type
Brocas
Wernickes
Conduction
Global
Naming
Poor
Poor
Poor
Poor
Presynaptic
Components:
The
presynaptic terminals contain
the synthetic machinery responsible for the
synthesis of all
neurotransmitters.
Synapse:
Although it makes up less than 1 percent of the total volume of the brain, the synaptic
compartment the space between the presynaptic and postsynaptic membranes contains the
mixture of neurotransmitters with the greatest influence on thought and behavior.
Postsynaptic Components
Neurotransmitter receptors are the sites of action for many of the psychotherapeutic and
psychoactive drugs
Chemical neurotransmission is the process involving the release of a neurotransmitter by one
neuron and the binding of the neurotransmitter molecule to a receptor on another neuron.
-The process of chemical neurotransmission is affected by most drugs used in psychiatry.
- Typical Antipsychotics, but not the serotonin-dopamine antagonists, are believed to exert their
effects mainly by blocking dopamine type 2 (D2) receptors
- Virtually all antidepressants are believed to exert their effects by increasing the amount of
serotonin or norepinephrine, or both, in the synaptic cleft
- Almost all benzodiazepine anxiolytics are believed to exert their effects on the GABAA
receptors.
Monoamine Receptors: Overview
Transmitter
Subtype
Dopamine
D2
D4
Transmitter
Subtype
Histamine
H1
Proposed Clinical
Relevance
Target of therapeutic and
extrapyramidal effects of
dopamine receptor
antagonists (typical
antipsychotics)
Target of serotonin-dopamine
antagonists (atypical
antipsychotics)
Proposed Clinical
Relevance
Antagonists produce
sedation, weight gain
[Dopamine]
When the D2 receptors are blocked by classic antipsychotic drugs, parkinsonian side effects
emerge.
Absence of D2 receptor activity dampen motor activity excessively, resulting in the bradykinesia
that typifies parkinsonism. At the other extreme, excess dopamine activity may result in
extraneous motor acts, such as tics.
Dopamine acts as a release-inhibiting factor by inhibiting the release of prolactin from the
anterior pituitary.
The diversity of serotonin receptors has initiated a significant effort to study the distribution of
serotonin receptor subtypes in pathological states and to design subtype-specific drugs that
may be of particular therapeutic benefit in specific conditions.
buspirone (BuSpar), a clinically effective anxiolytic, is a potent 5-HT1A agonist, and other 5HT1A agonists are being developed for the treatment of anxiety and depression.
Disorders in Psychiatry:
[Schizophrenia]
Definition: syndrome of unknown etiology characterized by disturbances in cognition, emotion,
perception, thinking, and behavior.
A. Clinical Course: Chronic
Phases: Prodromal Phase, Active Phase, Residual Phase
Active Phase: has symptoms such as hallucinations, delusions, and disorganized thinking.
Delusions
F. TREATMENT
1. Choice of Drug
a. First-Generation Antipsychotics (Typical Antipsychotics or Dopamine Receptor
Antagonist)
- Classic antipsychotics drugs, which are often effective in treatment of positive
symptoms of schizophrenia.
High Potency: e.g Haloperidol
- More likely to cause Extrapyramidal Side Effects (Akathisia, Acute Dystonia,
Pseudoparkinsonism)
Low Potency e.g chlorpromazine (Thorazine)
- More sedating, hypotensive, anticholinergic
Adverse Reaction: Tardive Dyskinesia
b. Second-Generation Antipsychotics (Atypical, Novel, Serotonin-Dopamine
Antagonist)
- Usually preferred and used more frequently than first generation antipsychotics.
- Equally if not more effective and with fewer side effects.
- Provide potent 5-HT2 receptor blockade and varying degrees of D2-Receptor
blockade.
- IMPROVE BOTH POSITIVE AND NEGATIVE SYMPTOMS.
- FEWER EPS
- DO NOT ELEVATE PROLACTIN LEVELS
- LESS LIKELY TO CAUSE TARDIVE DYSKINESIA
Clozapine
-
MOST ATYPICAL
Minimal or No EPS
Seldom causes Tardive Dyskinesia
Highly Sedating
Can cause weight gain.
[Mood Disorders]
Mood pervasive and sustained feeling tone that is experienced internally and that influences a
persons behavior and perception of the world.
a. Normal
b. Elevated
c. Depressed
Affect is the external expression of mood
Healthy persons experience a wide range of moods and have an equally large repertoire of
affective expressions; they feel in control of their moods and affects.
C. Age
-
D. Sociocultural
- Depressive Disorders are more common among single and divorced persons
compared to married persons.
- NO CORRELATION WITH SOCIOECONOMIC STATUS
- NO DIFFERENCE BETWEEN RACES OR RELIGIOUS GROUPS
II.
Etiology
A. Neurotransmitters
1. Serotonin has become the biogenic amine neurotransmitter most commonly
associated with depression (Serotonin Depletion).
- Serotonergic Agents are effective treatments.
2. Norepinephrine Abnormal Levels (Usually Low) of norepinephrine metabolites
are found in Blood, Urine, and CSF of depressed patients.
- Venlafaxine (Effexor) increases both Serotonin and Norepinephrine and is
used in depression for that reason.
3. Dopamine dopamine activity may be reduced in depression and increased in
mania.
- Drugs that reduce dopamine concentrations [e.g reserpine (Serpasil)] and
diseases that that reduce dopamine secretion (e.g Parkinsons Disease) are
associated with depressive symptoms.
- Drugs that increase dopamine concentrations such as, tyrosine, amphetamine,
buproprion (Wellbutrin) reduce the symptoms of depression.
- Dopamine D1 Receptors may be hypoactive in depression.
III.
Bipolar Disorder
Two Main Types:
Bipolar I characterized by occurrence of manic episodes with or without major depressive
episode.
Bipolar II characterized by atleast one (1) depressive episode with or without hypomanic
episode
Nurses Notes:
- Early anxiogenic effects of SSRI may aggrevate suicidal ideation and can be
managed by either: A. Reducing the Dose or B. Adding an Anxiolytic
- Insomnia can be managed with a benzodiazepine, zolpiden (Ambien), trazodone
(Desyrel), or mirtazapine (Remeron)
- TRYCYCLICS AND MAOIs are generally considered second or third line agents
because of their side effects and potential lethality in overdose.
- Increased risk of suicide as suicidally depressed patients begin to improve. They
have the physical energy to carry out the act, whereas before, they lacked the
will to do so. Paradoxical Suicide
- Ask about suicide ideas, especially plans to harm oneself. ASKING ABOUT
SUICIDE DOES NOT PLANT IDEAS.
- Do not hesitate to ask pateints if they want to die a straightforward approach
is the most effective
- Always ask about past suicide attempts, which can be related to future attempts
2. Buproprion
- Noradrenergic, dopaminergic drug with stimulant like properties.
- Generally well tolerated and may be particularly useful for depression marked by
anergy and psychomotor retardation.
- DEVOID OF SEXUAL SIDE EFFECTS
- MAY EXACERBATE ANXIETY AND AGITATION
- DOPAMINERGIC PROPERTIES MAY EXACERBATE PSYCHOSIS
3. Venflaxine and Duloxetine
- Serotonine-Norepinephrine Reuptake Inhibitors
- Particularly effective in Severe or Refractory cases of depression
- SIDE EFFECTS SIMILAR TO SSRI.
4. Tricyclics
- Highly effective but require dose titration.
- Side Effects:
(1) Anticholinergic Effects
(2) Cardiac Conducting Delays
(3) Orthostasis
- Secondary Amines: nortriptyline (OFTEN BETTER TOLERATED) than
- Tertiary Amines: amitriptyline (Elavil)
5. Augmentation Strategies in treatment-resistant or partially responsive patients:
- Lithium
- Amphetamines
- Buspirone
- Buproprion + SSRI
6. Monoamine Oxidase Inhibitor (MAOI)
- Safe with reasonable dietary restriction of tyramine-containing substances.
- Major depressive episodes that have atypical features or psychotic features or
that are related to Bipolar I disorder may preferentially respond to MAOI.
NURSES NOTES:
- MUST NOT BE ADMINESTERED 2-5 WEEKS AFTER DISCONTINUATION OF
AN SSRI OR OTHER SEROTONINERGIC DRUG
(1) Fluoxetine (Prozac) 5 Weeks
(2) Paroxetine (Paxil) 2 Weeks
(3) Clomipramine (Anafranil) must not be administered 2 weeks after
discontinuation of an MAOI
TREATMENT: [BIPOLAR DISORDER]
c. Lithium
- Mainstay treatment of bipolar disorders
- Blood Level: 0.8 1.2 mEq/L controls acute symptoms
- Response Time: 4-7 Days
Typical Side Effects:
Thirst
Polyurea (Nephrogenic Diabetes Insipidus)
Tremors
Metallic Taste
Cognitive Dulling
GI Upset
Hypothyroidism
Nurses Notes:
Pre-Treatment Workup:
(1) Complete Blood Count
(2) Electrocardiogran (ECG)
(3) Thyroid Function Tests
(4) Blood Urea Nitrogen
(5) Creatinine / Creatinine Clearance
(6) Pregnancy Test
NARROW THERAPEUTIC INDEX HIGH RISK FOR TOXICITY: WATCH OUT FOR
DEHYDRATION AND HYPONATREMIA! (MONITOR URINE SPECIFIC GRAVITY AND
ELECTROLYTE LEVELS)
PATIENTS WITH DEPRESSIVE BREAKTHOUGH ON LITHIUM SHOULD BE ASSESSED FOR
LITHIUM INDUCED HYPOTHYROIDISM
PSYCHOPHARMACOLOGY NOTES:
Acute Anxiety benzodiazepines
Chronic Anxiety benzodiazepines + antipsychotics
Benzodiazepine Overdose: flumazenil (Romazicon) Benzodiazepine Antagonist
NERVOUS SYSTEM:
A. Central Nervous System (CNS)
B. Peripheral Nervous System (PNS)
I.
4. Autonomic Nerves are organized into Sympathetic and Parasympathetic divisions that
provide motor innervation to smooth muscle, glands, and cardiac muscle.
a. SNS and PNS use 2 neurons in series to innervate target structures.
b. The cell body of the first neuron (preganglionic neuron) is found in the gray matter of
the CNS; the second neuron (postganglionic neuron) is in an autonomic ganglion in
the PNS.
c. Preganglionic sympathetic neuron cell bodies are found in the thoracic and upper
lumbar segments of the spinal cord from T1 through L2.
d. Preganglionic parasympathetic cell bodies either are found in the brainstem and exit
the brain in 1 of 4 (III, VII, IX, or X) or are found at sacral cord segments S2, S3, S4 and
exit the spinal cord with the ventral roots of S2 through S4 spinal nerves.
Sympathetic Division functions as an
emergency or catabolic system involved in
fight or flight responses and has a
widespread distribution.
Autonomic
Nerves
III. There
are 6
major components of the CNS, 5 of which develop from the 5 secondary vesicles of the
neural tube.
A. The 5 secondary vesicles are the telencephalon, diencephalon, mesencephalon,
metencephalon, and myelencephalon.
B. The telencephalon gives rise to the 2 cerebral hemispheres, the preoptic area, and most of
the basal ganglia.
1. Each hemisphere is divided into 4 lobes: frontal, parietal, occipital, and temporal.
2. Each hemisphere is highly convoluted by gyri that are separated by sulci; the central sulcus
and the lateral fissure are deep grooves that partially separate each hemisphere into the frontal,
parietal and temporal, and occipital lobes.
IV. The
functions to
trauma and
A. The
a
of
by
CNS
circulates
ventricles
and through
the
subarachnoid
space.
ventricular system
protect the brain from
transport CSF.
brain and spinal
cord float within
protective bath
CSF, which is
secreted
continuously
the choroid
plexus into
the
ventricles
inside the
and
through the
B. Each
part of the CNS contains a
ventricle or a
channel that interconnects
ventricles;
there are 2
lateral ventricles, a third and fourth
ventricle
1. Each lateral ventricle is located within a
cerebral hemisphere.
a. The lateral
ventricles are C shaped and follow, roughly,
the form of the cerebral hemispheres. They have parts situated in each of the 4 anatomic lobes.
b. The body of each lateral ventricle is in the parietal lobe, the anterior horn extends into the
frontal lobe, the inferior horn is in the temporal lobe, and the posterior horn is in the occipital
lobe.
c. Each lateral ventricle communicates with the third ventricle by way of an interventricular
foramen (of Monro); the interventricular foramen is at the junction of the anterior horn and the
body of each lateral ventricle.
2. The third ventricle is found in the midline between parts of the diencephalon and
communicates with the fourth ventricle by way of the cerebral aqueduct (of Sylvius), which
passes through the midbrain.
3. The fourth ventricle is located between the dorsal surfaces of the pons and upper medulla
and the ventral surface of the cerebellum.
4. The fourth ventricle is continuous with the central canal in the lower medulla, which extends
through the length of the spinal cord.
5. The fourth ventricle contains the only openings where CSF can exit the ventricular system
and enter the subarachnoid space; there are 2 lateral foramina of Luschka and a single foramen
of Magendie in the midline.